On September 27, 2024, Seelos Therapeutics, Inc. (the "Company") is scheduled to hold its 2024 Annual Meeting of Stockholders (the "Meeting"). However, the Company anticipates a lack of quorum due to insufficient stockholder participation. As a result, the Meeting will be postponed to Friday, October 25, 2024, at 8:00 a.m. Eastern Time. Stockholders of record as of August 19, 2024 will be entitled to vote at the rescheduled Meeting